Insider Selling: Integral Ad Science Holding Corp. (NASDAQ:IAS) CEO Sells 5,940 Shares of Stock

Integral Ad Science Holding Corp. (NASDAQ:IAS) CEO Lisa Utzschneider sold 5,940 shares of the firm’s stock in a transaction that occurred on Tuesday, January 7th. The stock was sold at an average price of $9.75, for a total transaction of $57,915.00. Following the completion of the transaction, the chief executive officer now owns 266,926 shares in the company, valued at $2,602,528.50. This represents a 2.18 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Integral Ad Science Stock Performance

Integral Ad Science stock traded up $0.48 during midday trading on Wednesday, reaching $10.20. 1,300,370 shares of the company traded hands, compared to its average volume of 1,082,354. The firm has a market capitalization of $1.66 billion, a price-to-earnings ratio of 51.00, a price-to-earnings-growth ratio of 1.46 and a beta of 1.46. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71. The business has a 50 day moving average of $11.00 and a two-hundred day moving average of $10.79. Integral Ad Science Holding Corp. has a 12 month low of $7.98 and a 12 month high of $17.53.

Integral Ad Science (NASDAQ:IAS) last issued its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The business had revenue of $133.50 million for the quarter, compared to the consensus estimate of $138.06 million. During the same quarter in the previous year, the firm earned ($0.09) earnings per share. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. As a group, research analysts predict that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on IAS. Oppenheimer cut their price objective on Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 13th. Craig Hallum cut their target price on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Scotiabank assumed coverage on shares of Integral Ad Science in a research note on Thursday, December 5th. They issued a “sector perform” rating and a $10.00 price target for the company. Piper Sandler reduced their target price on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating on the stock in a report on Wednesday, November 13th. Finally, Truist Financial lowered their target price on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, Integral Ad Science presently has a consensus rating of “Moderate Buy” and an average target price of $15.18.

Institutional Trading of Integral Ad Science

A number of large investors have recently made changes to their positions in the business. Healthcare of Ontario Pension Plan Trust Fund bought a new position in Integral Ad Science during the second quarter valued at $4,724,000. abrdn plc grew its holdings in Integral Ad Science by 12.5% during the 3rd quarter. abrdn plc now owns 2,147,656 shares of the company’s stock valued at $23,216,000 after purchasing an additional 237,930 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of Integral Ad Science by 47.6% during the third quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company’s stock valued at $7,756,000 after buying an additional 231,271 shares during the last quarter. Invenomic Capital Management LP lifted its stake in shares of Integral Ad Science by 57.4% during the 3rd quarter. Invenomic Capital Management LP now owns 585,309 shares of the company’s stock worth $6,327,000 after acquiring an additional 213,488 shares during the last quarter. Finally, Rice Hall James & Associates LLC purchased a new position in Integral Ad Science during the 3rd quarter valued at $1,795,000. 95.78% of the stock is currently owned by institutional investors.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.